Daiwa Securities Group Inc. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 68 filers reported holding UROGEN PHARMA LTD in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2024$10.0%480.0%0.00%
Q1 2024$10.0%480.0%0.00%
Q4 2023$10.0%480.0%0.00%
Q3 2023$1480.0%0.00%
Q2 2023$0480.0%0.00%
Q1 2023$0480.0%0.00%
Q4 2022$0480.0%0.00%
Q3 2022$0480.0%0.00%
Q2 2022$0480.0%0.00%
Q1 2022$0480.0%0.00%
Q4 2021$0
-100.0%
480.0%0.00%
Q3 2021$1,0000.0%480.0%0.00%
Q2 2021$1,0000.0%480.0%0.00%
Q1 2021$1,0000.0%480.0%0.00%
Q4 2020$1,000
-50.0%
48
-59.3%
0.00%
Q3 2020$2,000
-93.8%
1180.0%0.00%
-100.0%
Q2 2020$32,000
+1500.0%
1180.0%0.00%
Q1 2020$2,000
-33.3%
1180.0%0.00%
Q4 2019$3,0000.0%118
-11.3%
0.00%
Q3 2019$3,000
-40.0%
133
-11.3%
0.00%
Q2 2019$5,000
-16.7%
1500.0%0.00%
Q1 2019$6,0001500.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,155,862$38,571,00011.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 849,478$28,347,0004.49%
Horton Capital Management, LLC 108,670$3,626,0003.53%
Prosight Management, LP 217,686$7,264,0003.19%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$98,598,0002.35%
Phoenix Holdings Ltd. 834,739$27,663,0001.16%
SHIKIAR ASSET MANAGEMENT INC 67,025$2,237,0000.74%
MEITAV INVESTMENT HOUSE LTD 272,063$9,080,0000.66%
Clal Insurance Enterprises Holdings Ltd 17,666$529,388,0000.57%
Migdal Insurance & Financial Holdings Ltd. 738,302$24,637,0000.48%
View complete list of UROGEN PHARMA LTD shareholders